Clarissa Campbell appointed Tenure-Track Professor at the University of Vienna
CeMM congratulates Clarissa Campbell on her appointment as Tenure-Track Professor of Immunobiology at the University of Vienna. At CeMM, Clarissa Campbell will remain affiliated as Adjunct Principal Investigator. Her research group will be located at CeMM until the end of the year. Clarissa Campbell has been a Principal Investigator at CeMM since 2021, where she established an internationally recognized research group at the intersection of…
Giulio Superti-Furga appointed Founding Director of Graz-based CORI Institute
CeMM warmly congratulates its founding director, Giulio Superti-Furga, on his appointment as the scientific founding director of the newly established CORI Institute for Metabolism Research in Graz! The new institute was created through a unique partnership between the Austrian Academy of Sciences, the University of Graz, the Medical University of Graz, and the Graz University of Technology. CORI aims to become one of Europe’s leading…
19th Landsteiner Lecture with Jay Shendure
Where do babies come from? Most adults should be able to answer that question, at least in broad terms. But on the cellular level, the story remains astonishingly elusive – even to scientists. How does a single fertilized egg become a living organism composed of billions of highly specialized cells? It was this mystery that drew around 400 guests to the baroque festive hall of the Austrian Academy of Sciences for the 19th CeMM Landsteiner…
One Drug, Two Cleanup Crews: A built-in backup for targeted protein degradation
Targeted protein degradation has become one of the most promising strategies in modern drug discovery, enabling scientists to eliminate disease-causing proteins instead of merely blocking them. Now, researchers at CeMM, AITHYRA (both Institutes of the Austrian Academy of Sciences), and CeTPD have discovered that a single small molecule can recruit not one, but two independent protein disposal systems at the same time. This dual mechanism…
Maria Rescigno appointed to ERC Identification Committee
We congratulate our Scientific Director Maria Rescigno for beeing appointed by the European Commission to the high-level Identification Committee responsible for selecting future members of the European Research Council (ERC) Scientific Council! The six-member committee, composed of leading European scientists, will oversee the renewal process of the ERC Scientific Council as part of the preparations for Horizon Europe 2028–2034, the European…
A SAGA of instability: Without scaffold, a key driver of childhood leukemia falls apart
Researchers in the Seruggia group at St. Anna Children’s Cancer Research Institute (St. Anna CCRI) and the CeMM Research Center for Molecular Medicine have uncovered a new way to tackle acute myeloid leukemia (AML) cells in children: Instead of directly targeting the cancer-driving protein KAT2A – which can be compensated by a closely-related counterpart – the scientists destabilized it’s scaffold in the so-called SAGAcomplex. This indirect…
The tumor microbiota: A new frontier in cancer biology
Recent research shows that tumors in different organs host microbial communities capable of influencing cancer biology, immune responses, and the effectiveness of therapies, highlighting the need to standardize methods for studying intratumoral microbes. The tumor microbiota — which includes bacteria, fungi, viruses, and other microorganisms present in tumor tissue — is now considered an important component of the tumor microenvironment. An…
Christoph Bock receives EP PerMed grant for personalized treatment in children
CeMM PI Christoph Bock has been awarded funding through the European Partnership for Personalised Medicine (EP PerMed) under the 2025 Joint Transnational Call. His three-year project, titled “PharmocogenOmics for minimized Risk and better Efficacy in Children on high-dose Steroid Treatment (PhORECaST)”, focuses on improving the use of high-dose glucocorticoids, which remain a cornerstone therapy for acute immune-mediated diseases in children but…
CeMM Research Report 2025: Front Row Science
We are excited to present the CeMM Research Report 2025, Front Row Science! For this report, all CeMM members stepped out of their usual environments, the laboratories and the offices, and into society, engaging with the cultural scene. Each research and administrative group visited one of Vienna’s most prominent theaters and performance venues. There, they took the opportunity to discuss their work, the privilege of working in science, as well…
André Rendeiro elected to the Young Academy of the Austrian Academy of Sciences
We warmly congratulate André Rendeiro, Principal Investigator at CeMM, on his election to the Young Academy of the Austrian Academy of Sciences (ÖAW)! Rendeiro’s election to this prestigious body recognizes both his scientific achievements and his growing international visibility. His research at CeMM focuses on spatial and computational biology, with a particular emphasis on understanding complex tissue organization and its role in ageing and…
From pathology image to biological discovery: A journey with LazySlide
Microscopic images of human tissue are a cornerstone of biomedical research and clinical diagnostics. Yet despite their importance, these images often remain difficult to analyze systematically and to connect with other types of biological data. A new study led by CeMM Principal Investigator André Rendeiro and published in Nature Methods (DOI 10.1038/s41592-026-03044-7), introduces “LazySlide”, an open-source software tool that brings the power…
Become a Starting Principal Investigator at CeMM, Vienna (all genders)
We are currently recruiting two exceptionally innovative, creative, ambitious early-career scientists to join CeMM as Starting Principal Investigators within a new research program on pain and aging/healthy lifespan expansion. Join our highly committed CeMM Faculty consisting of 20 research group leaders contributing to the medicine of the future. Are you fascinated by the biology of aging and looking for a place where intellectual rigor and…
Researchers decode cancer’s genetic control panel one DNA letter at a time
Scientists in Davide Seruggia’s group at St. Anna Children’s Cancer Research Institute (St. Anna CCRI) and CeMM, together with collaborators at the Broad Institute of MIT and Harvard, have developed CRISPR-Millipede, a new CRISPR-based method that allows researchers to study regulatory DNA sequences at single-nucleotide resolution. Using this approach, the team uncovered how single mutations in regulatory sequences can help cancer cells evade…
Studying Food Safety Without Animal Testing: FWF Grant for Georg Busslinger
Georg Busslinger, Adjunct Principal Investigator at CeMM, has received a competitive grant from the Austrian Science Fund (FWF) to develop human organoid-based models for studying food-related host responses and food–drug interactions. The project focuses on so-called human gastrointestinal organoids, miniature lab-grown models of the gut made from human cells. These organoids closely mimic the structure and function of the human digestive…
A beautiful mind
It is with deep sorrow that we share the heartbreaking news of the passing of our dear colleague, Martin Watzenböck, who died at the age of 36. Martin was a PhD student at CeMM and MedUni Vienna in the group of Sylvia Knapp and completed his doctorate in 2023. During his time at CeMM and MedUni Vienna, his research focused on immune–microbe interactions in the lung, a topic he approached with both scientific rigor and genuine passion. Following…
